Mandibulofacial Dysostosis With Alopecia Results From ETAR Gain-Of-Function Mutations Via Allosteric Effects On Ligand Binding
January 2023
in “
Journal of Clinical Investigation
”
TLDR Specific mutations in a receptor cause facial abnormalities and hair loss.
The study identifies gain-of-function mutations in the endothelin receptor type A (ETAR), specifically p.E303K and p.Y129F, as causes of mandibulofacial dysostosis with alopecia (MFDA). These mutations enhance the receptor's affinity for endothelin 3 (ET3), leading to craniofacial abnormalities and alopecia. Mouse models with these mutations showed similar changes, which were partially reversed by deleting ET3, indicating the mutations' effects are largely ET3-dependent. The research highlights the role of allosteric effects in GPCR function and suggests potential drug targets for treating MFDA.